Benzinga's Top #PreMarket Gainers
September 05, 2014 at 08:05 AM EDT
Prana Biotechnology (NASDAQ: PRAN) jumped 26.17% to $2.70 in pre-market trading as the company received the FDA Orphan Designation for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
